TI
CTSO icon

Trexquant Investment’s Cytosorbents Corp CTSO Stock Holding History

Trexquant Investment’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-12,984
Closed -$103K – 1173
2020
Q4 		$103K Buy
12,984
+952
+8% +$7.97K 0.01% 966
2020
Q3 		$96K Sell
12,032
-16,449
-58% -$148K 0.01% 1141
2020
Q2 		$282K Buy
+28,481
New +$262K 0.02% 904

Other funds holding CTSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Trexquant Investment's CTSO Position: Q1 2021 in Review

Trexquant Investment sold out of Cytosorbents Corp (CTSO) in Q1 2021, closing a stake of 12,984 shares — an estimated $103K sold.

Trexquant Investment first reported a position in CTSO in Q2 2020 and held it in 3 quarters. The position peaked at $282K in Q2 2020. 96 funds tracked by Wall St. Rank hold CTSO as of Q1 2021.

  • Trexquant Investment reported no remaining Cytosorbents Corp position as of Q1 2021 after selling out during the quarter.
  • Trexquant Investment sold 12,984 Cytosorbents Corp shares in Q1 2021, an estimated $103K.
  • Trexquant Investment first reported a position in Cytosorbents Corp in Q2 2020 and held it in 3 quarters.
  • Trexquant Investment's Cytosorbents Corp position peaked at $282K in Q2 2020.
  • 96 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2021.

Based on Trexquant Investment's 13F filing for Q1 2021, filed 13 May 2021.